GlassScriptPhysician profile
Michelle Todesco
NPI 1154502342
$1,694.79
in general payments reported to CMS, 2019-2025
16 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 97% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $77.02 · 2024: $398 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $592.95 | 2025 | |
| Biogen, INC. | $366.21 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $160.26 | 2023-2024 | Myfembree |
| Millicent US INC | $100.24 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $89.92 | 2023-2025 | Slynd |
| Organon LLC | $83.32 | 2024-2025 | Nexplanon |
| Evofem Biosciences, INC. | $62.58 | 2023-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $46.98 | 2024-2025 | Veozah |
| Lilly USA, LLC | $43.07 | 2024 | Zepbound, Jardiance |
| Coopersurgical, INC. | $33.41 | 2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $29.09 | 2025 | |
| Exact Sciences Corporation | $21.39 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $20.65 | 2025 | Alinity M |
| Acella Pharmaceuticals, LLC | $16.43 | 2025 | NP Thyroid 60 |
| Ibsa Pharma INC. | $15.17 | 2023 | Tirosint, Licart |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.12 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Todesco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.